Dongmei Wang, Ph.D.
Dr. Dongmei Wang, a seasoned pharmaceutical industry professional with over 28 years of experience, is currently the EVP of Global Sales, Marketing and Project Management at Frontage Laboratories. She leads global efforts in promoting the company’s comprehensive drug discovery and development services. Since joining in February 2007, Dr. Wang has held several critical leadership roles including EVP and Global Head of CMC Services where she was responsible for CMC (Chemistry Manufacturing & Control) including organic synthesis, analytical services, formulation development, and manufacturing of GLP preclinical and GMP clinical trial materials. Under Dongmei’s leadership, the CMC team contributed to numerous IND, ANDA and NDA programs for many clients.
Prior to joining Frontage, Dr. Wang served as the Director of Analytical Chemistry at NovaDel Pharma Inc. in New Jersey where played a key role in the CMC sections of 505(b)(2) filings for several NDAs, including two sterile oral spray products approved by the FDA . Additionally, she led the Pharmaceutical Analysis and Control team at Therics Inc. supporting 3D printing oral drug product and bone repair development for IND and 510(k) filings.
Dr. Wang holds a Ph.D. in Chemistry from Iowa State University and performed postdoctoral research at the University of Chicago and earned an MS in Chemical Engineering from China Institute of Atomic Energy and a BS degree in Chemistry from Peking University. Earlier in her career, Dr. Wang was a lecturer at the Graduate University of Chinese Academy of Science in Beijing.
